Generated by AI
Revelation Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing immunologic therapies and diagnostics that modulate the innate immune system. Its current pipeline centers on product candidates designed to address inflammatory and infectious disease settings, including treatments for allergic rhinitis and chronic nasal congestion, rapid home-use diagnostics for respiratory viral infections, and intranasal immunomodulator approaches used alongside vaccination. The company also works on therapeutic programs targeting acute kidney injury, chronic kidney disease, and other conditions linked to dysregulated inflammation. Revelation Biosciences Inc. develops products intended for use in prevention and treatment across hospital, outpatient, and at-home care settings, with a focus on clinically relevant immune-response modulation. Based in San Diego, California, the company operates in the biotechnology sector and maintains a narrow, research-driven portfolio aimed at immune system therapeutics and diagnostics.
Website4660 La Jolla Village Drive
San Diego, CA, 92122
United States
Summary of Mar 30's posts. Generated by AI.
Summary of Mar 30's posts. Generated by AI.
Summary of Sep 10's posts. Generated by AI.
Summary of Jan 26's posts. Generated by AI.
Investors talking about REVB also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.